ERIN CHRISTIANO: Open Payments
NPI 1649987611 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$461 in 19 payments from 10 companies in 2025. Trend: 2023 $168 · 2024 $128 · 2025 $461
Food & beverage: $461
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 5 | $138 |
| Astellas Pharma US Inc | 2 | $61 |
| ABBVIE INC. | 2 | $50 |
| SHIELD THERAPEUTICS INC | 2 | $49 |
| MILLICENT US INC | 2 | $42 |
| Exeltis, USA Inc. | 2 | $40 |
| Biogen, Inc. | 1 | $29 |
| Hologic Sales and Service, LLC | 1 | $22 |
| CooperSurgical, Inc. | 1 | $17 |
| Sumitomo Pharma America, Inc. | 1 | $14 |
Products named: Veozah, LILETTA, ACCRUFER, SLYND, ZURZUVAE, THINPREP 2000 PROCESSOR, FEMLYV, INTRAROSA.
Industry payments across NY — which companies pay providers there.
